Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
18 sept. 2018 08h30 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through...
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
14 août 2018 07h30 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
07 août 2018 16h05 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Closes $2.625 million Convertible Note Financing
18 juil. 2018 16h05 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
12 juin 2018 08h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates
15 mai 2018 07h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics to Report First Quarter 2018 Financial Results on May 15, 2018
10 mai 2018 16h05 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated
27 avr. 2018 08h30 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., April 27, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance
16 avr. 2018 07h30 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic Business Updates
02 avr. 2018 16h01 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...